Correlation Between CARSALESCOM and BEXIMCO PHARMAGDR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CARSALESCOM and BEXIMCO PHARMAGDR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CARSALESCOM and BEXIMCO PHARMAGDR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CARSALESCOM and BEXIMCO PHARMAGDR REGS, you can compare the effects of market volatilities on CARSALESCOM and BEXIMCO PHARMAGDR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CARSALESCOM with a short position of BEXIMCO PHARMAGDR. Check out your portfolio center. Please also check ongoing floating volatility patterns of CARSALESCOM and BEXIMCO PHARMAGDR.

Diversification Opportunities for CARSALESCOM and BEXIMCO PHARMAGDR

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between CARSALESCOM and BEXIMCO is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding CARSALESCOM and BEXIMCO PHARMAGDR REGS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BEXIMCO PHARMAGDR REGS and CARSALESCOM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CARSALESCOM are associated (or correlated) with BEXIMCO PHARMAGDR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BEXIMCO PHARMAGDR REGS has no effect on the direction of CARSALESCOM i.e., CARSALESCOM and BEXIMCO PHARMAGDR go up and down completely randomly.

Pair Corralation between CARSALESCOM and BEXIMCO PHARMAGDR

Assuming the 90 days trading horizon CARSALESCOM is expected to generate 1.46 times less return on investment than BEXIMCO PHARMAGDR. But when comparing it to its historical volatility, CARSALESCOM is 2.44 times less risky than BEXIMCO PHARMAGDR. It trades about 0.05 of its potential returns per unit of risk. BEXIMCO PHARMAGDR REGS is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  39.00  in BEXIMCO PHARMAGDR REGS on October 8, 2024 and sell it today you would earn a total of  4.00  from holding BEXIMCO PHARMAGDR REGS or generate 10.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CARSALESCOM  vs.  BEXIMCO PHARMAGDR REGS

 Performance 
       Timeline  
CARSALESCOM 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CARSALESCOM has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, CARSALESCOM is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
BEXIMCO PHARMAGDR REGS 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in BEXIMCO PHARMAGDR REGS are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, BEXIMCO PHARMAGDR reported solid returns over the last few months and may actually be approaching a breakup point.

CARSALESCOM and BEXIMCO PHARMAGDR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CARSALESCOM and BEXIMCO PHARMAGDR

The main advantage of trading using opposite CARSALESCOM and BEXIMCO PHARMAGDR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CARSALESCOM position performs unexpectedly, BEXIMCO PHARMAGDR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BEXIMCO PHARMAGDR will offset losses from the drop in BEXIMCO PHARMAGDR's long position.
The idea behind CARSALESCOM and BEXIMCO PHARMAGDR REGS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated